MoneyWorks4Me

Windlas Biotech informs about certificate

11 Oct 2022 Evaluate

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Windlas Biotech has informed that it enclosed the Certificate received from Link Intime India, its Registrar and Share Transfer Agent for the Quarter ended September 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..